Profusa (NVACW) Cash & Equivalents (2021 - 2026)

Profusa posted quarterly Cash & Equivalents of $375000.0 for Q1 2026, down 78.91% on a QoQ basis from $1.8 million in Q4 2025.

Profusa (NVACW) has 6 years of Cash & Equivalents data on file, last reported at $375000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents changed N/A year-over-year to $375000.0; the trailing twelve-month figure through Mar 2026 stood at $375000.0 (changed N/A YoY), and the FY2025 full-year result was $1.8 million, up 830.89% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $375000.0, down from $1.8 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $3.0 million in Q3 2025 and bottomed at $533.0 in Q3 2024.
  • The 5-year median for Cash & Equivalents is $191000.0 (2024), against an average of $467105.6.
  • The widest annual swing landed in 2023, when Cash & Equivalents plunged 98.79%; it then surged 564440.34% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $193486.0 in 2022, then slumped by 97.66% to $4519.0 in 2023, then soared by 4126.6% to $191000.0 in 2024, then soared by 830.89% to $1.8 million in 2025, then sank by 78.91% to $375000.0 in 2026.
  • The last three Cash & Equivalents figures came in at $375000.0 (Q1 2026), $1.8 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.80 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.88 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 2.45 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.03 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.12 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.29 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 439.60 Mn
10 Profusa - - - 375,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 375,000.00
Dec 31, 2025 1.78 Mn
Sep 30, 2025 3.01 Mn
Dec 31, 2024 191,000.00
Sep 30, 2024 533.00
Jun 30, 2024 6,496.00
Mar 31, 2024 5,314.00
Dec 31, 2023 4,519.00
Sep 30, 2023 17,342.00
Jun 30, 2023 5,811.00
Mar 31, 2023 55,610.00
Dec 31, 2022 193,486.00
Sep 30, 2022 372,871.00
Jun 30, 2022 480,726.00
Mar 31, 2022 510,876.00
Dec 31, 2021 741,228.00